Task: Please answer the following question about the molecule with SMILES CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1
CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1
3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.